Hereditary angioedema: New therapeutic options for a potentially deadly disorder

BMC Blood Disorders

Volumn 10, Issue , 2010, Pages

  Eidelman, Frank J ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIFIBRINOLYTIC AGENT; BERINERT P; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4; DANAZOL; ICATIBANT; KALBITOR; KALLIKREIN INHIBITOR; RHUCIN; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ACNE; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASPHYXIA; ASTHENIA; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CREATINE KINASE BLOOD LEVEL; DEPRESSION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; FEVER; HEADACHE; HIGH RISK PATIENT; HUMAN; HYPOVOLEMIC SHOCK; INJECTION SITE REACTION; LIVER FUNCTION TEST; MENSTRUAL IRREGULARITY; MUSCLE SPASM; MYALGIA; NAUSEA; NOSE CONGESTION; PAIN; PATHOPHYSIOLOGY; PERIORBITAL EDEMA; RASH; REVIEW; RHINOPHARYNGITIS; SIDE EFFECT; SINUSITIS; STOMACH DISCOMFORT; SYMPTOM; UPPER RESPIRATORY TRACT INFECTION; VIRILIZATION; VOMITING; WEIGHT GAIN;

EID: 77952074232     PISSN: None     EISSN: 14712326     Source Type: Journal    
DOI: 10.1186/1471-2326-10-3     Document Type: Review

References (35)

1. Osler W. Hereditary angio-neurotic oedema. Am J Med Sci 1888, 95:362-367.
2. Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000, 356:213-217. 10.1016/S0140-6736(00)02483-1, 10963200.
3. Moore GP, Hurley WT, Pace SA. Hereditary angioedema. Ann Emerg Med 1988, 17:1082-1086. 10.1016/S0196-0644(88)80450-5, 3052191.
4. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 1992, 71:206-215.
5. Bowen T, Cicardi M, Bork K, Zuraw B, Frank M, Ritchie B, Farkas H, Varga L, Zingale LC, Binkley K, et al. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol 2008, 100(Suppl 2):30-40.
6. Agostoni A, Aygoren-Pursun E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo AJ, Cicardi M, Davis AE, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004, 114(Suppl 3):51-131.
7. Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med 2009, 15:69-78. 10.1016/j.molmed.2008.12.001, 19162547.
8. Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med 2001, 161:2417-2429. 10.1001/archinte.161.20.2417, 11700154.
9. Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med 2008, 359:1027-1036. 10.1056/NEJMcp0803977, 18768946.
10. Frank MM. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin North Am 2006, 26:653-668. 10.1016/j.iac.2006.09.005, 17085283.
11. Bouillet L, Longhurst H, Boccon-Gibod I, Bork K, Bucher C, Bygum A, Caballero T, Drouet C, Farkas H, Massot C, et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol 2008, 199:e481-484.
12. Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med 1976, 84:580-593.
13. Zuraw BL. Hereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new?. Ann Allergy Asthma Immunol 2008, 100(Suppl 2):13-18.
14. Davis AE. Mechanism of angioedema in first complement component inhibitor deficiency. Immunol Allergy Clin North Am 2006, 26:633-651. 10.1016/j.iac.2006.08.003, 17085282.
15. Bork K, Staubach P, Eckardt AJ, Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol 2006, 101:619-627. 10.1111/j.1572-0241.2006.00492.x, 16464219.
16. De Backer AI, De Schepper AM, Vandevenne JE, Schoeters P, Michielsen P, Stevens WJ. CT of angioedema of the small bowel. AJR Am J Roentgenol 2001, 176:649-652.
17. Bork K, Barnstedt SE. Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. J Am Dent Assoc 2003, 134:1088-1094.
18. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006, 119:267-274. 10.1016/j.amjmed.2005.09.064, 16490473.
19. Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C, Fay AC, Longhurst HJ, Morrison L, Price A, et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005, 139:379-394. 10.1111/j.1365-2249.2005.02726.x, 1809312, 15730382.
20. Weiler CR, van Dellen RG. Genetic test indications and interpretations in patients with hereditary angioedema. Mayo Clin Proc 2006, 81:958-972. 10.4065/81.7.958, 16835976.
21. CHMP assessment report for Firazyr. , http://www.ema.europa.eu/humandocs/PDFs/EPAR/firazyr/H-899-en6.pdf
22. Frigas E, Park M. Idiopathic recurrent angioedema. Immunol Allergy Clin North Am 2006, 26:739-751. 10.1016/j.iac.2006.09.004, 17085288.
23. Grigoriadou S, Longhurst HJ. Clinical Immunology Review Series: An approach to the patient with angio-oedema. Clin Exp Immunol 2009, 155:367-377. 10.1111/j.1365-2249.2008.03845.x, 2669512, 19220828.
24. Kalmar L, Hegedus T, Farkas H, Nagy M, Tordai A. HAEdb: a novel interactive, locus-specific mutation database for the C1 inhibitor gene. Hum Mutat 2005, 25:1-5. 10.1002/humu.20112, 15580551.
25. Zingale LC, Castelli R, Zanichelli A, Cicardi M. Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management. Immunol Allergy Clin North Am 2006, 26:669-690. 10.1016/j.iac.2006.08.002, 17085284.
26. Byrd JB, Adam A, Brown NJ. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am 2006, 26:725-737. 10.1016/j.iac.2006.08.001, 17085287.
27. Berinert [package insert]. 2009, Kankakee, IL: CSL Behring.
28. Craig TJ, Levy RJ, Wasserman RL, Bewtra AK, Hurewitz D, Obtulowicz K, Reshef A, Ritchie B, Moldovan D, Shirov T, et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 2009, 124:801-808. 10.1016/j.jaci.2009.07.017, 19767078.
29. KALBITOR [package insert]. 2009, Cambridge, MA: Dyax.
30. Deeks ED. Icatibant. Drugs 70:73-81. 10.2165/11204500-000000000-00000, 20030426.
31. Epstein TG, Bernstein JA. Current and emerging management options for hereditary angioedema in the US. Drugs 2008, 68:2561-2573. 10.2165/0003495-200868180-00003, 19093699.
32. Bork K, Bygum A, Hardt J. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. Ann Allergy Asthma Immunol 2008, 100:153-161. 10.1016/S1081-1206(10)60424-3, 18320917.
33. Danazol [package insert]. 2007, Philadelphia, PA: Lannett.
34. CINRYZE [package insert]. 2008, New York, NY: Lev Pharmaceuticals.
35. Zingale LC, Beltrami L, Zanichelli A, Maggioni L, Pappalardo E, Cicardi B, Cicardi M. Angioedema without urticaria: a large clinical survey. CMAJ 2006, 175:1065-1070. 1609157, 17060655.